Home › NCT07032506

Intrauterine Stent Placement Following Hysteroscopic Septum Resection

Recruiting

A Randomized Controlled Trial of Intrauterine Stent Placement Following Hysteroscopic Septum Resection

Who can join

Ages 18 and older · Women

Full eligibility criteria

Inclusion Criteria:

* Age 18 and above
* Patients electing to undergo hysteroscopic septoplasty following an informed consent and shared decision making process
* Uterine septum of at least 50% of the uterine cavity length as quantified on 3-dimensional saline infusion ultrasound

Exclusion Criteria:

* Unwilling or unable to provide informed consent
* History of prior uterine septum resection
* History of prior transmural uterine surgery
* Preexisting intrauterine adhesions or prior treatment for intrauterine adhesions
* Individuals in whom complete septum resection is unable to be performed as a single procedure

About the study

The study hopes to learn the best way to prevent internal scar tissue after septum removal. The use of an intrauterine foley catheter balloon may prevent the formation of adhesions following surgery.

What is being tested

Intraoperative placement of an inflated intrauterine pediatric foley catheter (procedure)
No Catheter placement (procedure)
Hormonal Therapy Agent (drug)
Oral antibiotics (drug)

Sponsor: Weill Medical College of Cornell University · Participants: 320 · Started: May 14, 2026

Contact the study team

Rodriq Stubbs, NP, MSN · Phone: 646-962-3276
Sarah Cambria · Phone: 646-962-2961

Official record on ClinicalTrials.gov — NCT07032506

Locations in the U.S.

Arkansas	Arkansas Fertility & Gynecology, Little Rock (Not yet recruiting)
New York	Weill Cornell Medicine, New York
Ohio	University Hospitals, Cleveland (Not yet recruiting)

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.